Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ATAI
ATAI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATAI News
AtaiBeckley Speculated to Attract Takeover Interest
2d ago
seekingalpha
AtaiBeckley Advances VLS-01 in Phase 2b Trial for Depression
2d ago
Newsfilter
AtaiBeckley to Join Russell 2000 Index
Jun 25 2026
seekingalpha
AtaiBeckley to Participate in Upcoming Investor Conferences
May 27 2026
Newsfilter
Trump's Executive Order Accelerates Psychedelic Drug Development
May 18 2026
Newsfilter
AtaiBeckley and PsyPAN Win Silver Award for Participant Advocacy
Apr 27 2026
NASDAQ.COM
AtaiBeckley Wins Silver Award in 2026 Patient Participant Index
Apr 27 2026
Newsfilter
AtaiBeckley Reports Significant Efficacy of EMP-01 in Social Anxiety Disorder
Apr 22 2026
Newsfilter
Apple CEO Transition Sparks Market Reactions
Apr 21 2026
CNBC
Apple's CEO Transition Sparks Market Reactions
Apr 21 2026
Newsfilter
Atai Beckley Shares Surge 21% Following Trump’s Psychedelic Treatment Review Acceleration
Apr 21 2026
NASDAQ.COM
Trump Directs Acceleration of Psychedelic Drug Reviews
Apr 21 2026
Fool
Trump Signs Executive Order to Accelerate Psychedelic Research
Apr 20 2026
CNBC
White House Psychedelics Executive Order Accelerates Research
Apr 20 2026
Newsfilter
AtaiBeckley Price Target Raised to $15 Amid Positive Drug Trial News
Apr 20 2026
stocktwits
Midday Market Moves: Notable Stock Fluctuations
Apr 20 2026
CNBC
Show More News
